LGALS3 and acute lymphoblastic leukemia: Because of this, the exact mechanism by which stromal produced extracellular Gal3 protects BCP-ALL cells against the conventional chemotherapy drugs vincristine and nilotinib, as found in our study, is difficult to determine.